Melinda Rezeli
Titel
Forskare
Organisation
046-2223721
Melinda [dot] Rezeli [at] elmat [dot] lth [dot] se
Publikationer (hämtat ur Lunds universitets publikationsdatabas)
författare
- 2013
- A Critical Evaluation of Inflammatory Markers in Huntington’s Disease Plasma
- Chromosome 19 Annotations with Disease Speciation - A First Report from the Global Research Consortium
- Clinical and Biomedical Mass Spectrometry - New Frontiers in Drug Developments and Diagnosis
- Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability
- Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability.
- 2012
- Large Scale Biobanking of Blood – The Importance of High Density Sample Processing Procedures
- Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry.
- Standardization and Utilization of Biobank Resources in Clinical Protein Sciene with Examples of Emerging Applications
- Understanding Drug Uptake and Binding within Targeted Disease Micro-Environments in Patients: A New Tool for Translational Medicine
- 2011
- Analysis of therapeutic peptides in human urine by combination of capillary zone electrophoresis-electrospray mass spectrometry with preparative capillary isotachophoresis sample pretreatment
- Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples
- Direct demonstration of tissue uptake of an inhaled drug: proof-of-principle study using matrix assisted laser desorption ionization mass spectrometry imaging
- Drug Localization in Different Lung Cancer Phenotypes by MALDI Mass Spectrometry Imaging
- MRM assay for quantitation of complement components in human blood plasma - a feasibility study on multiple sclerosis.
- Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels
- Translation science for targeted personalized medicine treatments
- 2010
- Characterization of PSA in clinical samples by mass spectrometry
- Characterization of PSA in clinical samples by mass spectrometry
- Identification of prostate specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms
- Isotope labeled internal standards (ILIS) as a basis for quality control in clinical studies using plasma samples
- MRM assay for quantification of complement components in human blood plasma
- MRM assay for quantification of complement components in human blood plasma
- Mass spectrometric strategy for clearcut identification of prostate specific antigen in clinical Samples
- 2009
- An analytical platform for clinical blood sample studies
- General approach for certain quantitative calculations for Instance of the variance of reversible adsorption to the capillary wall in CE
- Isotope labeled internal standards (ILIS) as the basis for QC-Control in human plasma analysis
- Multiplex approach for identification of PSA variants in clinical samples
- 2008
